384 related articles for article (PubMed ID: 10487666)
21. Effects of growth hormone treatment on cognitive function and head circumference in children born small for gestational age.
Hokken-Koelega A; van Pareren Y; Arends N
Horm Res; 2005; 64 Suppl 3():95-9. PubMed ID: 16439851
[TBL] [Abstract][Full Text] [Related]
22. Double blind trial comparing the effects of two doses of growth hormone in prepubertal patients with chronic renal insufficiency.
Hokken-Koelega AC; Stijnen T; De Jong MC; Donckerwolcke RA; De Muinck Keizer-Schrama SM; Blum WF; Drop SL
J Clin Endocrinol Metab; 1994 Oct; 79(4):1185-90. PubMed ID: 7525628
[TBL] [Abstract][Full Text] [Related]
23. Short children born small for gestational age and treated with growth hormone for three years have an important catch-down five years after discontinuation of treatment.
Fjellestad-Paulsen A; Simon D; Czernichow P
J Clin Endocrinol Metab; 2004 Mar; 89(3):1234-9. PubMed ID: 15001616
[TBL] [Abstract][Full Text] [Related]
24. Long-term efficacy and safety of two doses of growth hormone in short Japanese children born small for gestational age.
Tanaka T; Yokoya S; Seino Y; Togari H; Mishina J; Kappelgaard AM; Fujieda K
Horm Res Paediatr; 2011; 76(6):411-8. PubMed ID: 22156542
[TBL] [Abstract][Full Text] [Related]
25. Long-term effects of growth hormone (GH) treatment on body composition and bone mineral density in short children born small-for-gestational-age: six-year follow-up of a randomized controlled GH trial.
Willemsen RH; Arends NJ; Bakker-van Waarde WM; Jansen M; van Mil EG; Mulder J; Odink RJ; Reeser M; Rongen-Westerlaken C; Stokvis-Brantsma WH; Waelkens JJ; Hokken-Koelega AC
Clin Endocrinol (Oxf); 2007 Oct; 67(4):485-92. PubMed ID: 17561977
[TBL] [Abstract][Full Text] [Related]
26. Bone age progression during the first year of growth hormone therapy in pre-pubertal children with idiopathic growth hormone deficiency, Turner syndrome or idiopathic short stature, and in short children born small for gestational age: analysis of data from KIGS (Pfizer International Growth Database).
Darendeliler F; Ranke MB; Bakker B; Lindberg A; Cowell CT; Albertsson-Wikland K; Reiter EO; Price DA
Horm Res; 2005; 63(1):40-7. PubMed ID: 15627781
[TBL] [Abstract][Full Text] [Related]
27. The d3/fl-growth hormone (GH) receptor polymorphism does not influence the effect of GH treatment (66 microg/kg per day) or the spontaneous growth in short non-GH-deficient small-for-gestational-age children: results from a two-year controlled prospective study in 170 Spanish patients.
Carrascosa A; Esteban C; Espadero R; Fernández-Cancio M; Andaluz P; Clemente M; Audí L; Wollmann H; Fryklund L; Parodi L;
J Clin Endocrinol Metab; 2006 Sep; 91(9):3281-6. PubMed ID: 16804042
[TBL] [Abstract][Full Text] [Related]
28. Spontaneous 24-hour growth hormone profiles in prepubertal small for gestational age children.
Boguszewski M; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1995 Sep; 80(9):2599-606. PubMed ID: 7673401
[TBL] [Abstract][Full Text] [Related]
29. Children born small-for-gestational age: postnatal growth and hormonal status.
Albertsson-Wikland K; Boguszewski M; Karlberg J
Horm Res; 1998; 49 Suppl 2():7-13. PubMed ID: 9730665
[TBL] [Abstract][Full Text] [Related]
30. Growth response to an individualized versus fixed dose GH treatment in short children born small for gestational age: the OPTIMA study.
Jung H; Land C; Nicolay C; De Schepper J; Blum WF; Schönau E
Eur J Endocrinol; 2009 Feb; 160(2):149-56. PubMed ID: 19039085
[TBL] [Abstract][Full Text] [Related]
31. Attaining genetic height potential: Analysis of height outcomes from the ANSWER Program in children treated with growth hormone over 5 years.
Ross JL; Lee PA; Gut R; Germak J
Growth Horm IGF Res; 2015 Dec; 25(6):286-93. PubMed ID: 26363846
[TBL] [Abstract][Full Text] [Related]
32. Increased proportion of circulating non-22-kilodalton growth hormone isoforms in short children: a possible mechanism for growth failure.
Boguszewski CL; Jansson C; Boguszewski MC; Rosberg S; Carlsson B; Albertsson-Wikland K; Carlsson LM
J Clin Endocrinol Metab; 1997 Sep; 82(9):2944-9. PubMed ID: 9284724
[TBL] [Abstract][Full Text] [Related]
33. Puberty in growth hormone-treated children born small for gestational age (SGA).
Boonstra V; van Pareren Y; Mulder P; Hokken-Koelega A
J Clin Endocrinol Metab; 2003 Dec; 88(12):5753-8. PubMed ID: 14671164
[TBL] [Abstract][Full Text] [Related]
34. Growth and growth hormone treatment in short stature children born small for gestational age.
Labarta JI; Ruiz JA; Molina I; De Arriba A; Mayayo E; Longás AF
Pediatr Endocrinol Rev; 2009 Feb; 6 Suppl 3():350-7. PubMed ID: 19404234
[TBL] [Abstract][Full Text] [Related]
35. Growth hormone treatment of short children born small for gestational age: reappraisal of the rate of bone maturation over 2 years and metanalysis of height gain over 4 years.
de Zegher F; Butenandt O; Chatelain P; Albertsson-Wikland K; Jonsson B; Löfström A; Chaussain JL
Acta Paediatr Suppl; 1997 Nov; 423():207-12. PubMed ID: 9401574
[TBL] [Abstract][Full Text] [Related]
36. Dose-response study of biosynthetic human growth hormone (GH) in GH-deficient children: effects on auxological and biochemical parameters. Dutch Growth Hormone Working Group.
de Muinck Keizer-Schrama SM; Rikken B; Wynne HJ; Hokken-Koelega AC; Wit JM; Bot A; Drop SL
J Clin Endocrinol Metab; 1992 Apr; 74(4):898-905. PubMed ID: 1548357
[TBL] [Abstract][Full Text] [Related]
37. Growth response to growth hormone (GH) treatment relates to serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 in short children with various GH secretion capacities. Swedish Study Group for Growth Hormone Treatment.
Kriström B; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1997 Sep; 82(9):2889-98. PubMed ID: 9284715
[TBL] [Abstract][Full Text] [Related]
38. High serum levels of growth hormone (GH) and insulin-like growth factor-I (IGF-I) during high-dose GH treatment in short children born small for gestational age.
van Dijk M; Mulder P; Houdijk M; Mulder J; Noordam K; Odink RJ; Rongen-Westerlaken C; Voorhoeve P; Waelkens J; Stokvis-Brantsma J; Hokken-Koelega A
J Clin Endocrinol Metab; 2006 Apr; 91(4):1390-6. PubMed ID: 16464954
[TBL] [Abstract][Full Text] [Related]
39. Serum leptin in short children born small for gestational age: relationship with the growth response to growth hormone treatment. The Swedish Study Group for Growth Hormone Treatment.
Boguszewski M; Dahlgren J; Bjarnason R; Rosberg S; Carlsson LM; Carlsson B; Albertsson-Wikland K
Eur J Endocrinol; 1997 Oct; 137(4):387-95. PubMed ID: 9368507
[TBL] [Abstract][Full Text] [Related]
40. Height, muscle, fat and bone response to growth hormone in short children with very low birth weight born appropriate for gestational age and small for gestational age.
Berndt C; Schweizer R; Ranke MB; Binder G; Martin DD
Horm Res Paediatr; 2014; 82(2):81-8. PubMed ID: 24969628
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
